Novel and Promising Therapies for Diabetic Dyslipidemia to Mitigate Residual Cardiovascular Risk-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel and Promising Therapies for Diabetic Dyslipidemia to Mitigate Residual Cardiovascular Risk

Published:2024-08-20 Issue:16 Volume:13 Page:4915
ISSN:2077-0383
Container-title:Journal of Clinical Medicine
language:en
Short-container-title:JCM

Author:

Jialal Ishwarlal¹^ORCID,Gounden Verena²

Affiliation:

1. Department of Pathology and Internal Medicine, University of California-Davis, Sacramento, CA 95817, USA

2. Department of Clinical Biochemistry, University Hospital Galway, H91 YR71 Galway, Ireland

Abstract

Diabetes is a major risk factor for atherosclerotic cardiovascular disease (ASCVD), and the dyslipidemia of diabetes is pivotal in the genesis of this leading cause of increased morbidity and mortality that burdens diabetic patients [...]

Publisher

MDPI AG

Link

https://www.mdpi.com/2077-0383/13/16/4915/pdf

Reference21 articles.

1. Management of diabetic dyslipidemia: An update;Jialal;World J. Diabetes,2019

2. Lipid-lowering in diabetes: An update;Chait;Atherosclerosis,2024

3. Hyperlipidaemia in diabetes: Are there particular considerations for next-generation therapies?;Mourre;Diabetologia,2024

4. AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines;Grundy;Circulation,2019

5. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk;Mach;Eur. Heart J.,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP